breast cancer
Conditions
Interventions
None listed
Sponsors
Development department responsible party
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women aged 20 years or older at the time of informed consent 2. Patients with a confirmed diagnosis of breast cancer who are scheduled to undergo total or partial mastectomy 3. Patients who understood the information included in the informed consent document and have provided written consent through themselves or a legal representative prior to enrollment in the study
Exclusion criteria
Exclusion criteria: 1. Those participating in another clinical study or clinical research study at the time of informed consent 2. Those considered ineligible to participate in this study for medical reasons by the collaborative research principal investigator, etc. 3. Those with a preoperative diagnosis of mucinous carcinoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The usefulness is evaluated by comparing the measurement results (fluorescence intensity) of GCP-006 with the results of histopathological examination using a permanent pathological specimen. | — |
Contacts
Public Contactresponsible party Development department
GORYO Chemical, Inc.
Outcome results
None listed